Liu Jia1, Chen Cao1, Bi Jing1, Zhao Zigai1, Xu Bin1, Chen Xiaowei1, Lin Lexi1, Dai Jiren1, Zhang Yang1, Fu Yong2. 1. Department of ENT and Head & Neck Surgery, The Children's Hospital Zhejiang University School of Medicine, Zhejiang, Hangzhou, Binsheng Road 3333, 310051, China. 2. Department of ENT and Head & Neck Surgery, The Children's Hospital Zhejiang University School of Medicine, Zhejiang, Hangzhou, Binsheng Road 3333, 310051, China. Electronic address: 1307022@zju.edu.cn.
Abstract
OBJECTIVE: Balloon sinuplasty could restore nasal sinus drainage and airflow, limiting the damages and lowering the risks. This study aimed to assess the 3-year clinical efficacy, safety, and satisfactory degree of balloon sinuplasty through multiple aspects. Also the experience about treatment for postoperative adhesion was described. MATERIALS AND METHODS: A study was performed in 30 children who had failed medical therapy, and received Balloon sinuplasty of selected sinuses. Data in 3-year follow-up including questionnaire, VAS, CT, and nasal endoscopy findings were collected. Also postoperative nose-related medications or auxiliary therapies, revision surgery, and incidence of complications were collected. The satisfactory degree of children and parents were assessed. RESULTS: Compared to preoperative, the VAS scores, questionnaire (SN-5 or SNOT-22) scores and Lund-Mackay scores were significantly lower. In the 3-year follow-up, most of them did not require nose-related medications or auxiliary therapies, and were free of symptoms, or the symptoms did not affect their daily activities. None of the 30 children had complications of facial pain, teeth numbness, facial deformity, and dysosmia. However, nasal cavity adhesion still remained the most frequent. The satisfactory degree was relatively high. CONCLUSION: The 3-year follow-up demonstrated that balloon sinuplasty had high clinical efficacy and safety, the satisfactory degree of children and parents remained relatively high. Improved the upper respiratory infection and increased the immunity, which were considered effective methods to reduce the risk of recurrence. Nasal spraying of steroids and nasal irrigation in three months after surgery cold help prevent the nasal cavity adhesion.
OBJECTIVE: Balloon sinuplasty could restore nasal sinus drainage and airflow, limiting the damages and lowering the risks. This study aimed to assess the 3-year clinical efficacy, safety, and satisfactory degree of balloon sinuplasty through multiple aspects. Also the experience about treatment for postoperative adhesion was described. MATERIALS AND METHODS: A study was performed in 30 children who had failed medical therapy, and received Balloon sinuplasty of selected sinuses. Data in 3-year follow-up including questionnaire, VAS, CT, and nasal endoscopy findings were collected. Also postoperative nose-related medications or auxiliary therapies, revision surgery, and incidence of complications were collected. The satisfactory degree of children and parents were assessed. RESULTS: Compared to preoperative, the VAS scores, questionnaire (SN-5 or SNOT-22) scores and Lund-Mackay scores were significantly lower. In the 3-year follow-up, most of them did not require nose-related medications or auxiliary therapies, and were free of symptoms, or the symptoms did not affect their daily activities. None of the 30 children had complications of facial pain, teeth numbness, facial deformity, and dysosmia. However, nasal cavity adhesion still remained the most frequent. The satisfactory degree was relatively high. CONCLUSION: The 3-year follow-up demonstrated that balloon sinuplasty had high clinical efficacy and safety, the satisfactory degree of children and parents remained relatively high. Improved the upper respiratory infection and increased the immunity, which were considered effective methods to reduce the risk of recurrence. Nasal spraying of steroids and nasal irrigation in three months after surgery cold help prevent the nasal cavity adhesion.
Authors: Adam J Kimple; Brent A Senior; Edward T Naureckas; David A Gudis; Ted Meyer; Sarah E Hempstead; Helaine E Resnick; Dana Albon; Wayne Barfield; Margo McKenna Benoit; Daniel M Beswick; Eliza Callard; Shelagh Cofer; Veronica Downer; E Claire Elson; Angela Garinis; Ashleigh Halderman; Lisa Hamburger; Meagan Helmick; Michael McCown; Cameron J McKinzie; Hanna Phan; Kenneth Rodriguez; Ronald C Rubenstein; Ashley Severin; Gopi Shah; Ambika Shenoy; Brittney Sprouse; Frank Virgin; Bradford A Woodworth; Stella E Lee Journal: Int Forum Allergy Rhinol Date: 2022-02-22 Impact factor: 5.426